Importantly, transfer of IL-22BP-deficient Th cells into either IL-22BP-sufficient or -deficient RAG mice resulted in less disease as compared to mice receiving WT Th cells, indicating that Th cell-derived IL-22BP was the biologically dominant source for pathogenic IL-22BP production during IBD (149). Here, IL22RA2 is linked to inflammatory bowel disease.